ZW-439

N/A

Report date: 2026/04/09 20:00:21

Base Information

Drug NameZW-439

Drug Alias NameZW-439ZW439

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionGTPase Ras inhibitorsAnti-CLDN18

TargetsGTPase RasClaudin-18 splice variant 2

Therapy Area/IndicationsPancreatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryCanada

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesZymeworks Inc

China Registration ClassN/A

Active CompaniesZymeworks Inc

Inactive CompaniesN/A

Active IndicationsPancreatic Neoplasms

Inactive IndicationsN/A

ATC CodeN/A